P293 eHealth: Individualisation of MMX mesalamine treatment and optimization of disease course via a self-managed web-based solution in active ulcerative colitis
2014; Oxford University Press; Volume: 8; Linguagem: Inglês
10.1016/s1873-9946(14)60414-1
ISSN1876-4479
AutoresN Pedersen, Johan Burisch, L. Martinsen, Mette Bennedsen, Peter Thielsen, Sally Bell, Zsuzsanna Végh, Anne Haaber, Dana Ďuricová, Tine Jess, Ebbe Langholz, Pia Munkholm,
Tópico(s)Interprofessional Education and Collaboration
ResumoP293 eHealth: Individualisation of MMX mesalamine treatment and optimization of disease course via a self-managed web-based solution in active ulcerative colitis N. Pedersen1,2 *, J. Burisch3, L. Martinsen4, M. Bennedsen5, P. Thielsen6, S. Bell7, Z. Vegh3, A. Haaber8, D. Duricova9, T. Jess10, E. Langholz11, P. Munkholm3. 1Herlev University Hospital, Department of Gastroenterology, Copenhagen, Denmark, 2University, Gastroenterology, Copenhagen, Denmark, 3University of Copenhagen, Gastroenterology, Herlev, Denmark, 4Nykobing Falster Hospital, Gastroenterology, Nykobing Falster, Denmark, 5Frederikssund Hospital, Gastroenterology, Frederikssund, Denmark, 6Herlev University Hospital, Gastroenterology, Herlev, Denmark, 7University of Melbourne, Gastroenterology, Melbourne, Australia, 8Gentofte Hospital, Gastroenterology, Gentofte, Denmark, 9Charls University Hospital, IBD research centre ISCARE a.s., Herlev, Denmark, 10State Serum Institute, Epidemiology, Copenhagen, Denmark, 11Gentofte, Gastroenterology, Gentofte, Denmark
Referência(s)